Prof. Dr. Ernst Wagner

Prof. Wagner is a professor of Pharmaceutical Biotechnology at the Ludwig-Maximilians-Universität (LMU) and the Center of Nanoscience in Munich, Germany. Previously (1991-2001), he was the Director Cancer Vaccines & Gene Therapy at Boehringer Ingelheim in Vienna, Austria, where he supervised the first-in-world polymer-based human gene therapy trial in 1994.

Prof. Wagner is an Academician of the European Academy of Sciences, a Controlled Release Society (CRS) College of Fellows member, a German Society for Gene Therapy board member, and the Journal of Gene Medicine Editor-in-Chief. He has authored more than 475 publications with almost 45,000 citations. His current academic research projects focus on the targeted delivery of nucleic acids (including mRNA) and protein therapeutics.